{"id":"W2148923175","doi":"10.1200/jco.2009.26.5520","title":"Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":385,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Medicine; Glioma; Concomitant; Internal medicine; Nausea; Anaplastic astrocytoma; Dacarbazine; Oncology; Progression-free survival; Phases of clinical research; Vomiting; Tumor progression; Radiation therapy; Surgery; Chemotherapy; Gastroenterology; Cancer; Astrocytoma; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006332539,0.0001865496,0.002620433,0.0003439042,0.00003472485,0.000006106412,0.0001962033,0.0003835656,0.0001186804],"category_scores_gemma":[0.007826502,0.0001169047,0.0006769033,0.000235376,0.0002014364,0.00006298182,0.00009355683,0.001323095,0.000007828495],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008907123,"about_ca_system_score_gemma":0.0009646007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008159429,"about_ca_topic_score_gemma":0.0005625366,"domain_scores_codex":[0.9941282,0.0006233446,0.004245575,0.0002638169,0.0004589146,0.0002801483],"domain_scores_gemma":[0.9945189,0.002115454,0.001987979,0.0003559389,0.0006143216,0.0004073874],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3788289,0.2766175,0.08412441,0.00002333049,0.0009878732,0.01816415,0.0005855493,0.000001419162,0.01124001,0.00009890913,0.003728151,0.2255998],"study_design_scores_gemma":[0.5554785,0.3411367,0.09229756,0.0001434857,0.0008516581,0.0006250708,0.0005525653,0.00002039468,0.001575431,0.000126193,0.007079305,0.0001131248],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897382,0.0002029908,0.00000108714,0.004355236,0.004356987,0.001029374,0.000005795977,0.000006219951,0.0003041127],"genre_scores_gemma":[0.9980364,0.000123978,0.0004322677,0.0002165669,0.001120146,0.00002144548,0.000001709684,0.00001612623,0.00003139385],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2254867,"threshold_uncertainty_score":0.9369619,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1162981086235023,"score_gpt":0.4910405256228433,"score_spread":0.3747424169993411,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}